Autism: Clinical Trials

2 trials for Autism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Terminated 2

Follow Autism: new trials by email Literature Review of Autism trials Research Report on Autism

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social Interactions
Memantine Hydrochloride, Placebo - Autism, Autism Spectrum Disorder
Phase 3TerminatedMassachusetts General Hospital252018-11-132026-02-25
Synthetic Human Secretin in Children With Autism and Gastrointestinal Dysfunction
RG1068 (Synthetic Human Secretin) - Autism
Phase 3TerminatedRepligen Corporation2002-04-012005-11-21

Narrower conditions

Autistic Disorder (2)  ·  Autism Spectrum Disorder (1)  ·  non-verbal learning disabilities (1)

Broader conditions

Child Development Disorders, Pervasive (2)  ·  Mental Disorders (2)  ·  Neurodevelopmental Disorders (2)  ·  Autism Spectrum Disorder (1)

Interventions

Memantine (1)  ·  Secretin (1)

Sponsors

Massachusetts General Hospital (1)  ·  Repligen Corporation (1)

Countries

United States (1)

Top investigators

Gagan Joshi, MD (1)

Results publications

PMID 36006807, PMID 37811711